Todd Bennett joins Mabtech as Chief Commercial Officer

Mabtech has appointed Todd Bennett as Chief Commercial Officer, effective July 20, 2026. In this role, Todd leads Mabtech's global commercial organization and is based in the US.

"We are delighted to have Todd join our team," said Phill Keefe, CEO of Mabtech. "His track record across the life science tools and diagnostics industry, combined with his deep experience in multiplexing, makes him an excellent fit to lead our commercial organization going forward."

Todd has held chief commercial officer and senior commercial leadership positions at several publicly traded and venture-backed life science tools and diagnostics companies, including Luminex, Quantum-Si, Immucor, Binx Health, and Nuclein. Earlier in his career, he held commercial leadership positions at Abbott Laboratories and Roche Diagnostics. His time at Luminex gave him particular depth in multiplexing technology, an area closely connected to Mabtech's EYRAplex platform.

"I want to understand our people, science, products, customers, and what has made Mabtech such a respected company," said Todd. "I'm excited to bring my experience to Mabtech and to work together with teams across the organization to build on this strong foundation."

Mabtech welcomes Todd to the team.